Tomlinson, B, Chan, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2024, Volume 20, Issue 4, Pages 175-179
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 3.9
2.What is the impact of type 2 diabetes mellitus on CYP450 metabolic activities?
Tomlinson, B, Li, YH
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2023, Volume 19, Issue 12, Pages 867-870
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 3.9 发表年影響因子: 3.9
Tomlinson, B, Chow, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2021, Volume 17, Issue 12, Pages 1353-1361
收錄情况: WOS SCOPUS
WOS核心合集引用: 5 2023影響因子: 3.9 发表年影響因子: 4.936
4.Pharmacokinetics of current and emerging treatments for hypercholesterolemia
Tomlinson, B, Chan, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2020, Volume 16, Issue 5, Pages 371-385
收錄情况: WOS SCOPUS
WOS核心合集引用: 9 2023影響因子: 3.9 发表年影響因子: 4.481
5.Metformin transporter pharmacogenomics: insights into drug disposition-where are we now?
Chan, P, Shao, L, To More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2018, Volume 14, Issue 11, Pages 1149-1159
收錄情况: WOS SCOPUS
WOS核心合集引用: 16 2023影響因子: 3.9 发表年影響因子: 3.487
Tomlinson, B, Hu, M, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2017, Volume 13, Issue 2, Pages 211-223
收錄情况: WOS SCOPUS
WOS核心合集引用: 16 2023影響因子: 3.9 发表年影響因子: 3.151
7.Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes
Tomlinson, B, Hu, M, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2016, Volume 12, Issue 11, Pages 1267-1271
收錄情况: WOS SCOPUS
WOS核心合集引用: 10 2023影響因子: 3.9 发表年影響因子: 3.027
Hu, M, Tomlinson, B
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2014, Volume 10, Issue 1, Pages 51-65
收錄情况: WOS SCOPUS
WOS核心合集引用: 33 2023影響因子: 3.9 发表年影響因子: 2.831
Chan, SW, Hu, M, Tom More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2012, Volume 8, Issue 7, Pages 767-790
收錄情况: WOS SCOPUS
WOS核心合集引用: 14 2023影響因子: 3.9 发表年影響因子: 2.944
Hu, MA, To, KKW, Mak More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2011, Volume 7, Issue 1, Pages 49-62
收錄情况: WOS SCOPUS
WOS核心合集引用: 41 2023影響因子: 3.9 发表年影響因子: 3.119
11.Pharmacokinetic evaluation of lanreotide
Hu, MA, Tomlinson, B
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2010, Volume 6, Issue 10, Pages 1301-1312
收錄情况: WOS SCOPUS
WOS核心合集引用: 12 2023影響因子: 3.9 发表年影響因子: 3.374
本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器
Copyright © 2018 澳門科技大學學者庫